Literature DB >> 22469174

Chapter 4 fexofenadine hydrochloride.

Lokesh Kumar1, Md Shahnwaj Alam, Chhuttan Lal Meena, Rahul Jain, Arvind K Bansal.   

Abstract

Entities:  

Year:  2010        PMID： 22469174     DOI： 10.1016/S1871-5125(09)34004-2

Source DB:  PubMed          Journal:  Profiles Drug Subst Excip Relat Methodol        ISSN： 1871-5125


× No keyword cloud information.
  5 in total

1.  Improvement of effect of water-in-oil microemulsion as an oral delivery system for fexofenadine: in vitro and in vivo studies.

Authors:  E Gundogdu; I Gonzalez Alvarez; E Karasulu
Journal:  Int J Nanomedicine       Date:  2011-08-12

2.  Coronavirus disease 2019 drug discovery through molecular docking.

Authors:  Sweta Singh; Hector Florez
Journal:  F1000Res       Date:  2020-06-03

3.  Quality by Design for the Development and Analysis of Enhanced In-Situ Forming Vesicles for the Improvement of the Bioavailability of Fexofenadine HCl in Vitro and in Vivo.

Authors:  Ali M Nasr; Mona K Qushawy; Mahmoud M Elkhoudary; Aya Y Gawish; Sameh S Elhady; Shady A Swidan
Journal:  Pharmaceutics       Date:  2020-04-29       Impact factor: 6.321

4.  Improved Dissolution Rate and Intestinal Absorption of Fexofenadine Hydrochloride by the Preparation of Solid Dispersions: In Vitro and In Situ Evaluation.

Authors:  Basanth Babu Eedara; Dinesh Nyavanandi; Sagar Narala; Prabhakar Reddy Veerareddy; Suresh Bandari
Journal:  Pharmaceutics       Date:  2021-02-27       Impact factor: 6.321

5.  Solid Form and Phase Transformation Properties of Fexofenadine Hydrochloride during Wet Granulation Process.

Authors:  Suye Li; Hengqian Wu; Yanna Zhao; Ruiyan Zhang; Zhengping Wang; Jun Han
Journal:  Pharmaceutics       Date:  2021-05-27       Impact factor: 6.321
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.